US approves Agilent buy of Varian

* EU had previously approved deal with conditions

WASHINGTON, May 17 (BestGrowthStock) – U.S. antitrust regulators
have approved U.S. electronics equipment maker Agilent
Technologies Inc’s (A.N: ) buy of Varian Inc (VARI.O: ), the
Federal Trade Commission said on Monday.

Agilent pursued the $1.5 billion deal in a bid to boost its
fast-growing bioanalytical measurement business.

The FTC announced the approval in a list of approved
transactions that it puts out several times a week.

The European Union had given antitrust approval to the deal
in January with some conditions.

The Varian deal will boost Agilent’s product offerings in
the life sciences and environmental sectors and pave its
expansion into new markets such as nuclear magnetic resonance
imaging. The acquisition was announced in July last year.

Agilent competes with PerkinElmer Inc (PKI.N: ), Thermo
Fisher Scientific Inc (TMO.N: ), Waters Corp (WAT.N: ) and Life
Technologies Corp (LIFE.O: ) in the bioanalytical business.

Stock Market Research

(Reporting by Diane Bartz, editing by Gerald E. McCormick)

US approves Agilent buy of Varian